The amino terminus of JAK3 is necessary and sufficient for binding to the common gamma chain and confers the ability to transmit interleukin 2-mediated signals
- PMID: 9192665
- PMCID: PMC21258
- DOI: 10.1073/pnas.94.13.6910
The amino terminus of JAK3 is necessary and sufficient for binding to the common gamma chain and confers the ability to transmit interleukin 2-mediated signals
Abstract
JAK3 is a protein tyrosine kinase that specifically associates with the common gamma chain (gammac), a shared subunit of receptors for interleukin (IL) 2, 4, 7, 9, and 15. Patients deficient in either JAK3 or gammac presented with virtually identical forms of severe combined immunodeficiency (SCID), underscoring the importance of the JAK3-gammac interaction. Despite the key roles of JAK3 and gammac in lymphocytic development and function, the molecular basis of this interaction remains poorly understood. In this study, we have characterized the regions of JAK3 involved in gammac association. By developing a number of chimeric JAK3-JAK2 constructs, we show that the binding specificity to gammac can be conferred to JAK2 by transferring the N-terminal domains of JAK3. Moreover, those JAK3-JAK2 chimeras capable of binding gammac were also capable of reconstituting IL-2 signaling as measured by inducible phosphorylation of the chimeric JAK3-JAK2 protein, JAK1, the IL-2 receptor beta chain, and signal transducer and activator of transcription 5A. Subsequent deletion analyses of JAK3 have identified the N-terminal JH7-6 domains as a minimal region sufficient for gammac association. Furthermore, expression of the mutant containing only the JH7-6 domains effectively competed with full-length JAK3 for binding to gammac. We conclude that the JH7-6 domains of JAK3 are necessary and sufficient for gammac association. These studies offer clues toward a broader understanding of JAK-mediated cytokine signaling and may provide a target for the development of novel therapeutic modalities in immunologically mediated diseases.
Figures
Similar articles
-
Autosomal SCID caused by a point mutation in the N-terminus of Jak3: mapping of the Jak3-receptor interaction domain.EMBO J. 1999 Mar 15;18(6):1549-58. doi: 10.1093/emboj/18.6.1549. EMBO J. 1999. PMID: 10075926 Free PMC article.
-
Delineation of the regions of interleukin-2 (IL-2) receptor beta chain important for association of Jak1 and Jak3. Jak1-independent functional recruitment of Jak3 to Il-2Rbeta.J Biol Chem. 1998 Apr 24;273(17):10719-25. doi: 10.1074/jbc.273.17.10719. J Biol Chem. 1998. PMID: 9553136
-
The pseudokinase domain is required for suppression of basal activity of Jak2 and Jak3 tyrosine kinases and for cytokine-inducible activation of signal transduction.J Biol Chem. 2002 Dec 6;277(49):47954-63. doi: 10.1074/jbc.M205156200. Epub 2002 Sep 25. J Biol Chem. 2002. PMID: 12351625
-
Combined immunodeficiencies due to defects in signal transduction: defects of the gammac-JAK3 signaling pathway as a model.Immunobiology. 2000 Aug;202(2):106-19. doi: 10.1016/s0171-2985(00)80058-3. Immunobiology. 2000. PMID: 10993286 Review.
-
Signalling by cytokines interacting with the interleukin-2 receptor gamma chain.Cytokines Cell Mol Ther. 1998 Dec;4(4):243-56. Cytokines Cell Mol Ther. 1998. PMID: 10068058 Review.
Cited by
-
JAK-STAT signaling in inflammation and stress-related diseases: implications for therapeutic interventions.Mol Biomed. 2023 Nov 8;4(1):40. doi: 10.1186/s43556-023-00151-1. Mol Biomed. 2023. PMID: 37938494 Free PMC article. Review.
-
Case Report: Mutations in JAK3 causing severe combined immunodeficiency complicated by disseminated Bacille Calmette-Guérin disease and Pneumocystis pneumonia.Front Immunol. 2022 Nov 17;13:1055607. doi: 10.3389/fimmu.2022.1055607. eCollection 2022. Front Immunol. 2022. PMID: 36466884 Free PMC article.
-
Transcriptome Analysis Reveals Key miRNA-mRNA Pathways in Ovarian Tissues of Yunshang Black Goats With Different Kidding Numbers.Front Endocrinol (Lausanne). 2022 May 19;13:883663. doi: 10.3389/fendo.2022.883663. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35663314 Free PMC article.
-
Deregulation of the Interleukin-7 Signaling Pathway in Lymphoid Malignancies.Pharmaceuticals (Basel). 2021 May 8;14(5):443. doi: 10.3390/ph14050443. Pharmaceuticals (Basel). 2021. PMID: 34066732 Free PMC article. Review.
-
Role of intracellular signaling pathways and their inhibitors in the treatment of inflammation.Inflammopharmacology. 2021 Jun;29(3):617-640. doi: 10.1007/s10787-021-00813-y. Epub 2021 May 17. Inflammopharmacology. 2021. PMID: 34002330 Review.
References
-
- Paul W E, Seder R A. Cell. 1994;76:241–251. - PubMed
-
- Ihle J N, Witthuhn B A, Quelle F W, Yamamoto K, Silvennoinen O. Annu Rev Immunol. 1995;13:369–398. - PubMed
-
- Taniguchi T. Science. 1995;268:251–255. - PubMed
-
- Schindler C, Darnell J E J. Annu Rev Biochem. 1995;64:621–651. - PubMed
-
- Darnell J E J, Kerr I M, Stark G R. Science. 1994;264:1415–1421. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous